ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025

Glucagon-Like Peptide-2 as a Potential Biomarker for Nonalcoholic Fatty Liver Disease in Children with Obesity: Preliminary Assessment of Metabolic Associations and Underlying Mechanisms.

Shu-Juan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.